Study details
Enrolling now
Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma
Rebecca E Kotcher, MD
NCT IDNCT06626334ClinicalTrials.gov data as of Apr 2026
Target enrollment
75
Study length
about 1.9 years
Ages
18+
Locations
1 site in PA
About this study
Researchers are testing if blue light therapy improves pain and inflammation in adults with painful rib fractures. The trial is comparing bright blue light to white light, and usual lighting conditions, to see which treatment helps control pain better.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Bright Blue Light
- 2.Use Bright Full-Spectrum (White) Light
- 3.Use Usual Ambient Light
Primary goalChest wall pain intensity, with incentive spirometer use
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low4%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Chest wall pain intensity, with incentive spirometer use
Secondary: Chest wall pain intensity, at rest, IL-6 concentration